ETHAN ITTNER: Open Payments
NPI 1083908248 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 53 payments from 17 companies in 2025. Trend: 2023 $985 · 2024 $1,239 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $182 |
| ABBVIE INC. | 6 | $123 |
| Axsome Therapeutics, Inc. | 5 | $115 |
| Teva Pharmaceuticals USA, Inc. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| Bausch Health US, LLC | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, Auvelity, FANAPT, AUSTEDO XR, APLENZIN, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
